(S,R,2R,2'R)-N,N'-((5S,15S)-8-carbamoyl-6,14-dioxo-2,18-dithia-7,13-diazanonadecane-5,15-diyl)bis(6-amino-2-((S)-14,18-bis(4-aminobutyl)-5-(benzo[d][1,3]dioxol-5-ylmethyl)-11-(4-methoxybenzyl)-4,7,10,13,16-pentaoxo-8-((R)-1-phenylethyl)-2,5,8,11,14,17-hexaazanonadecanamido)hexanamide)

ID: ALA4472244

Chembl Id: CHEMBL4472244

PubChem CID: 155535670

Max Phase: Preclinical

Molecular Formula: C118H177N25O23S2

Molecular Weight: 2378.00

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CNCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCCCCC(NC(=O)[C@H](CCSC)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN(CCCCN)C(=O)CN(Cc1ccc(OC)cc1)C(=O)CN(C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CNC)[C@H](C)c1ccccc1)C(N)=O)Cc1ccc(OC)cc1)[C@H](C)c1ccccc1)Cc1ccc2c(c1)OCO2

Standard InChI:  InChI=1S/C118H177N25O23S2/c1-81(87-29-11-9-12-30-87)142(110(152)75-138(104(146)65-126-3)69-85-42-48-98-100(63-85)165-79-163-98)77-108(150)140(67-83-38-44-89(161-5)45-39-83)73-106(148)136(59-27-24-56-123)71-102(144)129-92(34-15-20-52-119)114(156)132-94(36-17-22-54-121)116(158)134-96(50-61-167-7)113(155)128-58-26-19-33-91(112(125)154)131-118(160)97(51-62-168-8)135-117(159)95(37-18-23-55-122)133-115(157)93(35-16-21-53-120)130-103(145)72-137(60-28-25-57-124)107(149)74-141(68-84-40-46-90(162-6)47-41-84)109(151)78-143(82(2)88-31-13-10-14-32-88)111(153)76-139(105(147)66-127-4)70-86-43-49-99-101(64-86)166-80-164-99/h9-14,29-32,38-49,63-64,81-82,91-97,126-127H,15-28,33-37,50-62,65-80,119-124H2,1-8H3,(H2,125,154)(H,128,155)(H,129,144)(H,130,145)(H,131,160)(H,132,156)(H,133,157)(H,134,158)(H,135,159)/t81-,82-,91?,92+,93+,94-,95-,96+,97+/m1/s1

Standard InChI Key:  BTTRVMFPMCISMV-LQUJFCIRSA-N

Alternative Forms

  1. Parent:

    ALA4472244

    ---

Associated Targets(Human)

HCC4017 (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 2378.00Molecular Weight (Monoisotopic): 2376.2891AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Singh J, Shukla SP, Desai TJ, Udugamasooriya DG..  (2016)  Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.,  24  (18): [PMID:27485601] [10.1016/j.bmc.2016.07.045]

Source